Patching up broken hearts: cardiac cell therapy gets a bioengineered boost
1Stanford Cardiovascular Institute, Stanford, CA 94305, USA.
Cell Stem Cell
|December 7, 2014
Abstract:
Preclinical and clinical studies for cardiac cell therapy have only seen moderate success due to poor engraftment and survival of transplanted cells. In this issue of Cell Stem Cell, Ye et al. (2014) employ a growth-factor-loaded fibrin patch and show improved cardiovascular cell survival after cell transplantation into a porcine model of ischemia reperfusion.


